Add office photos
Employer?
Claim Account for FREE
St. Xavier's High School
3.7
based on 412 Reviews
Video summary
Company Overview
Company Locations
Working at St. Xavier's High School
Company Summary
Focuses on enhancing English literacy to promote academic success, aiming for universal literacy across multiple districts.
Overall Rating
3.7/5
based on 412 reviews
3% above
industry average
Critically rated for
Promotions
Work Policy
Work from office
90% employees reported
Monday to Saturday
82% employees reported
Strict timing
68% employees reported
No travel
51% employees reported
View detailed work policy
Top Employees Benefits
Office cab/shuttle
29 employees reported
Job/Soft skill training
26 employees reported
Professional degree assistance
20 employees reported
Free meal
17 employees reported
View all benefits
About St. Xavier's High School
Founded in1869 (156 yrs old)
India Employee Count--
Global Employee Count1k-5k
India HeadquartersMumbai, Maharashtra, India
Websitestxaviershighschool.org
Primary Industry
Other Industries
--
Are you managing St. Xavier's High School's employer brand? To edit company information,
claim this page for free
View in video summary
Literacy in the present day scenario plays a vital role in determining the standard of civilization of a particular country. Universal literacy is, therefore, the goal of every nation. Considering the importance of English, the accepted global motion and to keep pace with any other advanced countries of the world, the St. Xavier’s Group of Schools evolves its policies to stress on high standard English literacy which pave the way to brilliant academic success. With this end in view, the group endeavors to open schools in each and every district of the country so as to impart high quality education through English medium.
Report error
Managing your company's employer brand?
Claim this Company Page for FREE
St. Xavier's High School Ratings
based on 412 reviews
Overall Rating
3.7/5
How AmbitionBox ratings work?
5
197
4
102
3
48
2
17
1
48
Category Ratings
3.6
Skill development
3.5
Work-life balance
3.4
Company culture
3.4
Job security
3.4
Salary
3.4
Work satisfaction
3.2
Promotions
St. Xavier's High School is rated 3.7 out of 5 stars on AmbitionBox, based on 412 company reviews.This rating reflects an average employee experience, indicating moderate satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at St. Xavier's High School
based on 360 reviews
3.7
Rated by 210 Women
Rated 3.7 for Skill development and 3.6 for Work-life balance
3.7
Rated by 150 Men
Rated 3.4 for Work-life balance and 3.4 for Job security
Work Policy at St. Xavier's High School
based on 39 reviews in last 6 months
Work from office
90%
Hybrid
10%
St. Xavier's High School Reviews
Top mentions in St. Xavier's High School Reviews
+ 5 more
Compare St. Xavier's High School with other companies in Education & Training Industry
 |  Change Company |  Change Company |  Change Company | |
|---|---|---|---|---|
Overall Rating | 3.7/5 based on 412 reviews | 3.5/5 based on 409 reviews | 4.0/5 based on 409 reviews | 4.0/5 based on 410 reviews |
Highly Rated for |  No highly rated category | No highly rated category | Skill development Work-life balance Company culture | Skill development Company culture Work-life balance |
Critically Rated for | Promotions | Promotions Salary Work satisfaction | Salary | Promotions |
Primary Work Policy | Work from office 90% employees reported | Work from office 70% employees reported | Work from office 90% employees reported | Work from office 72% employees reported |
Rating by Women Employees | 3.7 Good rated by 210 women | 3.3 Average rated by 134 women | 4.1 Good rated by 325 women | 3.6 Good rated by 107 women |
Rating by Men Employees | 3.7 Good rated by 150 men | 3.6 Good rated by 250 men | 3.8 Good rated by 39 men | 4.2 Good rated by 239 men |
Job security | 3.4 Average | 3.4 Average | 3.7 Good | 3.7 Good |
View more
St. Xavier's High School Salaries
St. Xavier's High School salaries have received with an average score of 3.4 out of 5 by 412 employees.
Assistant Teacher
(75 salaries)
Unlock
₹1.4 L/yr - ₹4.5 L/yr
School Teacher
(57 salaries)
Unlock
₹1.2 L/yr - ₹3.5 L/yr
PRT Teacher
(31 salaries)
Unlock
₹2.4 L/yr - ₹6 L/yr
Principal
(27 salaries)
Unlock
₹6 L/yr - ₹10.9 L/yr
Primary Teacher
(20 salaries)
Unlock
₹1.1 L/yr - ₹3.6 L/yr
Teacher Educator
(15 salaries)
Unlock
₹2 L/yr - ₹5.7 L/yr
School Principal
(14 salaries)
Unlock
₹6 L/yr - ₹11.6 L/yr
English Teacher
(13 salaries)
Unlock
₹1.5 L/yr - ₹4.2 L/yr
PGT Teacher
(12 salaries)
Unlock
₹3 L/yr - ₹5.5 L/yr
Computer Teacher
(12 salaries)
Unlock
₹1.7 L/yr - ₹4.8 L/yr
St. Xavier's High School Interview Questions
St. Xavier's High School Jobs
Popular Designations St. Xavier's High School Hires for
Popular Skills St. Xavier's High School Hires for
Current Openings
St. Xavier's High School News
View all
St. Jude Scientist Charles Mullighan Elected Fellow of the Royal Society of London
- Charles G. Mullighan, a senior deputy director at St. Jude Comprehensive Cancer Center, has been elected as a Fellow of the Royal Society of London for his contributions to pediatric cancer research, particularly in acute leukemia.
- Mullighan's research focuses on the genomic understanding and treatment of acute leukemia, leading to the identification of novel molecular subtypes of childhood acute lymphoblastic leukemia (ALL) through advanced genomic sequencing and bioinformatics.
- His work has revolutionized precision medicine in pediatric oncology by identifying critical genomic drivers of leukemogenesis, paving the way for targeted therapies with higher efficacy and reduced toxicity for pediatric patients.
- Mullighan's leadership at St. Jude includes roles in pathology research, the Center of Excellence for Leukemia Studies, and as the William E. Evans Endowed Chair, emphasizing the institution's commitment to advancing leukemia research.
- His election to the Royal Society highlights the collaborative efforts and supportive environment at St. Jude, showcasing the institution's innovative approach to combating childhood diseases through science.
- The recognition of Mullighan's work by the Royal Society acknowledges his dedication to improving survival rates and quality of life for children with leukemia globally, aligning with St. Jude's mission of transformative impact.
- Mullighan's research contributions, alongside those of distinguished members of St. Jude, reflect the hospital's international leadership in biomedical research, placing him among elite scientists worldwide.
- The integration of genomics in pediatric oncology, exemplified by Mullighan's work, has led to personalized treatment approaches based on genetic biomarkers, enhancing remission rates and reducing relapse in childhood leukemia patients.
- St. Jude's commitment to comprehensive research and clinical excellence has significantly improved childhood cancer survival rates through innovative treatments over the years, emphasizing a relentless pursuit of collaboration and innovation.
- Mullighan's research extends beyond molecular discovery to influence diagnostic standards and therapeutic guidelines globally, translating breakthroughs into improved clinical care across diverse healthcare settings.
Bioengineer | 20 May, 2025
Corpay and Computer Guidance Corporation Release New Case Study Highlighting Integrated AP Automation
- Corpay and Computer Guidance Corporation released a joint case study highlighting their integrated accounts payable automation solution for mutual customer, S.T. Wooten.
- Through the eCMS Connect for Corpay integration, customers can securely automate their payment process within the ERP system, improving efficiency.
- The API-based solution enables real-time data exchange between Corpay's platform and Computer Guidance's eCMS ERP system, enhancing visibility and accuracy.
- The case study features S.T. Wooten, a construction contractor, showcasing how the integrated solution helped streamline payment workflows and drive cost savings.
Global Fintech Series | 19 May, 2025
New Study Uncovers Targetable Mechanism Driving High-Risk Gene in Pediatric Medulloblastoma
- A recent study by researchers at St. Jude Children’s Research Hospital reveals a potential targeted therapeutic approach for high-risk pediatric medulloblastoma associated with ELP1 gene mutations.
- The study focuses on SHH-medulloblastoma, a malignant brain tumor in children linked to ELP1 gene mutations and sheds light on the underlying molecular mechanisms.
- ELP1 deficiency in children predisposes them to SHH-medulloblastoma, leading researchers to investigate its role in tumor development using mouse models.
- The study uncovered a link between ELP1 loss and decreased activity of the tumor suppressor protein p53, critical in maintaining cellular integrity.
- ELP1 deficiency was found to enhance the activity of MDM2, an enzyme that degrades p53, ultimately promoting tumor growth.
- Inhibiting MDM2 in preclinical models with ELP1 deficiency reactivated p53, restraining tumor proliferation and extending survival, suggesting a promising therapeutic avenue.
- The research holds promise for developing targeted therapies like MDM2 inhibitors for pediatric brain tumors, potentially improving treatment safety and efficacy over current standard therapies.
- Financial support from organizations like St. Baldrick’s Foundation and National Cancer Institute played a key role in advancing this research, highlighting the importance of dedicated funding in pediatric cancer studies.
- The collaborative effort involving experts from various disciplines and institutions globally emphasizes the significance of interdisciplinary approaches in tackling childhood cancers.
- The study's translational path towards clinical trials with MDM2 inhibitors showcases accelerated potential in offering targeted treatment options for pediatric medulloblastoma patients with ELP1 deficiency.
- This groundbreaking research not only elucidates the molecular mechanisms behind pediatric brain tumors but also paves the way for safer, more personalized treatments, marking a significant advancement in the field of pediatric oncology.
Bioengineer | 16 May, 2025
Vitamin supplement could slow down vision loss, study finds
- A vitamin supplement designed to improve metabolism in the eye may help slow down damage to the optic nerve in people with glaucoma, as per a study published in Cell Reports Medicine.
- Researchers at Karolinska Institutet conducted experiments elevating homocysteine levels in rats with glaucoma, finding it did not worsen the condition or link to disease progression in humans.
- Homocysteine was identified as a byproduct of glaucoma, not its cause, leading researchers to explore how metabolism in the retina could be affected.
- Abnormalities in how the retina processed certain vitamins were discovered, indicating a slower local metabolism contributing to glaucoma progression.
- Experiments with B vitamins and choline on mice and rats with glaucoma showed halted optic nerve damage or slowed progression, even without reducing eye pressure.
- A clinical trial is underway at St. Erik Eye Hospital testing the vitamin supplement's efficacy in humans with different types of glaucoma to potentially revolutionize treatment.
- The study paves the way for a new approach in managing glaucoma by focusing on the health of the retina and optic nerve, offering hope for vision preservation.
- If successful, this vitamin treatment could lead to safer and more accessible options for glaucoma patients, leveraging well-known vitamins for other health purposes.
- This research highlights the potential impact of metabolic health on glaucoma and aims to confirm the protective effects observed in animals through clinical trials.
- The study sheds light on the promising role of vitamin supplements in slowing or halting vision loss in individuals with glaucoma, potentially improving outcomes for millions at risk.
Knowridge | 9 May, 2025
St. Jude Neurologist Richard Finkel Included in TIME100 Health List
- Richard S. Finkel, MD, of St. Jude Children’s Research Hospital, is recognized on Time Magazine’s TIME100 Health list for 2025 for his contributions to pediatric neurology and translational neuroscience.
- Dr. Finkel leads the Center for Experimental Neurotherapeutics (CENT) at St. Jude, focusing on debilitating neurological disorders affecting children globally, expanding the hospital's mission to address a wider range of health challenges.
- His notable achievement includes conducting the first in utero treatment of spinal muscular atrophy using risdiplam, a breakthrough altering the treatment landscape for genetic neuromuscular disorders.
- The in utero therapy showed significant efficacy by preventing manifestations of SMA and increasing the production of survival motor neuron (SMN) protein, potentially transforming therapeutic strategies for such conditions.
- Published in the New England Journal of Medicine, the study highlights the potential of prenatal interventions for genetic neuromuscular disorders and offers insights into early pharmacological interventions and immune tolerance mechanisms.
- Dr. Finkel's work extends to various neurological diseases, emphasizing gene modulation, neurometabolic stabilization, and neuroprotective strategies to accelerate the development of novel interventions tailored to pediatric patients.
- This transformative approach challenges treatment paradigms by advocating for early intervention during gestation, which could reshape global health policies in the realm of fetal medicine and pediatric neurology.
- St. Jude's commitment to eradicating childhood diseases includes a shift towards tackling neurological disorders, leveraging molecular biology and clinical trials to advance therapeutic development and share discoveries globally.
- Dr. Finkel's recognition reflects his pioneering impact on pediatric neurology, emphasizing hope and healing for children facing neurological conditions through innovative treatment approaches and collaborative research efforts.
- His work signifies a significant evolution in pediatric health, pushing boundaries in pediatric neurotherapeutics and paving the way for improved outcomes in devastating neurological diseases affecting children worldwide.
Bioengineer | 9 May, 2025
St. Luke’s Invests $30M+ in GE HealthCare Advanced MRI with AI & iRT
- St. Luke’s University Health Network has made a $30M investment in MRI technology and service from GE HealthCare.
- The investment aims to expand patient access to advanced imaging, reduce scan times, and enhance image quality.
- The MRI technology features wider bores to improve patient comfort and reduce feelings of claustrophobia.
- The investment includes AI capabilities that significantly enhance the quality of diagnostic images and speed at which they are acquired.
Hitconsultant | 29 Apr, 2025
Machine Perfusion Extends Travel Range for Donor Hearts
- Donor hearts are now being transported over longer distances due to advancements in machine perfusion technology, revolutionizing cardiac transplantation logistics.
- Machine perfusion allows hearts to remain metabolically active during transit by supplying essential nutrients and maintaining physiological conditions.
- St. Vincent’s Hospital in Sydney has embraced normothermic machine perfusion (NMP), increasing heart transplant reach and efficacy.
- The technology extends heart preservation to up to eight hours, facilitating acceptance of organs from previously inaccessible regions.
- The innovation removes logistical barriers by enabling the procurement of donor hearts from distant locales, enhancing organ availability.
- Research shows that outcomes using machine perfusion are comparable to traditional cold storage methods, ensuring donor heart function post-transplant.
- Continuous delivery of oxygenated perfusate during transport via machine perfusion reduces hypoxic injury and supports heart repair processes.
- The introduction of machine perfusion marks a significant shift in heart transplantation practices, providing hope to patients globally.
- Ongoing advancements in perfusate compositions and real-time functional assessments aim to further optimize heart transport processes.
- Normothermic machine perfusion is poised to transform heart transplantation by overcoming geographic constraints and expanding donor organ access.
Bioengineer | 27 Apr, 2025
New Insights into FOXR2 Activation Across Brain Tumors Enhance Diagnostic Precision and Patient Care
- Researchers at St. Jude Children’s Research Hospital have discovered that FOXR2 activation extends beyond CNS neuroblastoma to a wider array of pediatric brain tumors.
- This finding challenges the conventional belief that FOXR2 activation is exclusive to CNS neuroblastoma and calls for a reevaluation of diagnostic and treatment approaches.
- Genomic analysis across various brain tumor types revealed FOXR2 activation in tumors beyond neuroblastoma, including high-grade gliomas and pineoblastomas.
- The identification of FOXR2 activation in aggressive brain tumors emphasizes the need to understand its oncogenic mechanisms and implications for treatment resistance.
- Clinically, FOXR2 activation was linked to different treatment responses, highlighting the importance of integrating molecular profiling with traditional diagnostic methods.
- Complex genomic events leading to FOXR2 activation were uncovered, suggesting the necessity for advanced diagnostic tools for accurate detection.
- The study underscores the significance of combining various data layers to enhance tumor classification and customize therapeutic strategies for improved outcomes.
- The broader implications of FOXR2 activation in pediatric brain tumors raise questions about molecular drivers, tumor microenvironments, and potential therapeutic targets.
- This research aligns with the shift towards precision oncology, emphasizing tailored therapies based on molecular characteristics for optimal patient care.
- The study was supported by grants from institutions like the National Cancer Institute, reflecting a collaborative effort to advance pediatric cancer research.
Bioengineer | 17 Apr, 2025
St. Basil’s first female CEO Diana Horvatovic’s heartfelt leadership lessons
- Diana Horvatovic, the CEO of St. Basil’s NSW/ACT, shares her transition from finance to aged care, driven by a longing for more meaning and impact.
- Her journey reveals a commitment to purpose and lessons on leading with heart and making a difference.
- Starting in finance, Diana mastered skills like strategic thinking but felt a gap between her work and desired impact.
- Her move to aged care was driven by a search for genuine meaning and a desire to champion the dignity of older Australians.
- Joining the aged care sector, Diana aimed to create better systems, nurture teams, and ensure exceptional care for the elderly.
- Her focus on trust and compassion became central to her leadership approach at St. Basil’s.
- Diana emphasizes that true leadership involves emotional intelligence, resilience, and connecting with people on a personal level.
- She advocates for greater female representation in leadership and acknowledges the evolving nature of the aged care industry.
- Diana's work is not just about strategic growth but making a lasting impact by ensuring every resident feels valued and respected.
- Her journey serves as a reminder for aspiring leaders to step out of their comfort zones and pursue impactful work guided by purpose.
Dynamicbusiness | 14 Apr, 2025
World Series Champion Dead in Dominican Republic Nightclub Roof Collapse: Report
- At least 44 people have died and 160 were injured when the roof of a nightclub in the Dominican Republic collapsed.
- Among the deceased is former MLB pitcher and World Series champion Octavio Dotel, who was attending a concert at the nightclub.
- Dotel was initially reported missing but was later confirmed to have been rescued alive, and tragically, he died while being transported to a nearby hospital.
- Dotel had a successful 15-year career in the MLB, winning the World Series in 2011 with the St. Louis Cardinals.
Mensjournal | 9 Apr, 2025
Powered by
St. Xavier's High School Offices
Compare St. Xavier's High School with other companies in Education & Training Industry
Pratham Education Foundation
4.0
Aptech
3.5
Eurokids
4.0
Pearson Education India
3.9
GD Goenka Public School
3.2
British Council
3.6
ICFAI University
3.6
GUS Education India
3.1
Tradeshala
4.5
Global Indian International School
4.0
Triumphant Institute of Management Education
3.7
Sunstone
3.8
Nettur Technical Training Foundation
3.8
Mahendra’s Institute
3.2
QSpiders
3.6
Christian Medical College
4.1
SRM University
3.5
KLAY Schools
3.6
Indian Institute of Technology Gandhinagar
4.1
VIT University
4.1
Edit your company information by claiming this page
Contribute & help others!
You can choose to be anonymous
Trending Companies in Education & Training Industry
IIT Bombay
Education & Training
4.5
• 303 reviews
GD Goenka Public School
Education & Training
3.2
• 435 reviews
GUS Education India
Education & Training, EdTech, IT Services & Consulting
3.1
• 449 reviews
O P Jindal Global University
Education & Training
3.8
• 224 reviews
Hero Vired
Education & Training
4.3
• 211 reviews
Brainware University
Education & Training
3.0
• 167 reviews
AFICIONADO TECHNOLOGIES
Education & Training
4.2
• 33 reviews
Shiv Nadar University
Education & Training
4.1
• 107 reviews
Jawahar Navodaya Vidyalaya
Education & Training
4.4
• 339 reviews
Sri Chaitanya Educational Institutions
Education & Training
3.8
• 973 reviews
GLA University
Education & Training
3.8
• 193 reviews
Zee Learn
Education & Training
3.7
• 233 reviews
St. Xavier's High School FAQs
When was St. Xavier's High School founded?
St. Xavier's High School was founded in 1869. The company has been operating for 156 years primarily in the Education & Training sector.
Where is the St. Xavier's High School headquarters located?
St. Xavier's High School is headquartered in Mumbai, Maharashtra. It operates in 3 cities such as Ghaziabad, Howrah, Greater Noida. To explore all the office locations, visit St. Xavier's High School locations.
Does St. Xavier's High School have good work-life balance?
St. Xavier's High School has a Work-Life Balance Rating of 3.5 out of 5 based on 400+ employee reviews on AmbitionBox. 73% employees rated St. Xavier's High School 4 or above, while 27% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read St. Xavier's High School work-life balance reviews for more details.
Is St. Xavier's High School good for career growth?
Career growth at St. Xavier's High School is rated as moderate, with a promotions and appraisal rating of 3.2. 27% employees rated St. Xavier's High School 3 or below, while 73% employees rated it 4 or above on promotions / appraisal. This rating suggests that while some employees view growth opportunities favorably, there is scope for improvement based on employee feedback. We recommend reading St. Xavier's High School promotions / appraisals reviews for more detailed insights.
What are the cons of working in St. Xavier's High School?
Working at St. Xavier's High School does have some drawbacks that potential employees should consider. The company is poorly rated for promotions / appraisal, work satisfaction and salary & benefits, based on 400+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Trusted by over 1.5 Crore job seekers to find their right fit company
85 Lakh+
Reviews
10L+
Interviews
4 Crore+
Salaries
1.5 Cr+
Users
Contribute to help millions
AmbitionBox Awards
Get AmbitionBox app
Made with ❤️ in India. Trademarks belong to their respective owners. All rights reserved © 2025 Info Edge (India) Ltd.
Follow Us
